Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › imsidolimab

imsidolimab

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of imsidolimab

4 trials tracked of imsidolimab.

4Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 4
  1. Phase 2 A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis Completed
  2. Phase 2 A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris Completed
  3. Phase 2 A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa Completed
  4. Phase 2 A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Imsidolimab shows GPPPGA clearance in generalized pustular psoriasis flare at 4 weeks
Dermatology RCT
Imsidolimab shows GPPPGA clearance in generalized pustular psoriasis flare at 4 weeks A New Drug Clears Severe Skin Flares Fast
This phase 3 randomized controlled trial in 45 patients with a GPP flare found that a single intravenous dose of imsidolimab led to a higher…
A new medicine stops severe skin flares quickly without causing dangerous side effects for most patients
NEJM Evid Apr 28, 2026